| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 27, 2004
Revised on March 9, 2005
Accepted on March 10, 2005
From the Division of Cardiology (F.I.), Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pa; Division of Cardiovascular Medicine (M.Z., B.H., V.A.F., J.A.E., V.V.P.) and the Department of Radiology (R.Z.), University of Pennsylvania, Philadelphia, Pa; and the Department of Pharmacology and Medical Research Center for Gene Regulation (H.K.), Chonnam National University Medical School, Gwangju, South Korea.
* To whom correspondence should be addressed. E-mail: vickas.patel{at}uphs.upenn.edu.
Hop is an unusual homeobox gene expressed in the embryonic and adult heart. Hop acts downstream of Nkx2-5 during development, and Nkx2-5 mutations are associated with cardiac conduction system (CCS) defects. Inactivation of Hop in the mouse is lethal in half of the expected null embryos. Here, we show that Hop is expressed strongly in the adult CCS. Hop-/- adult mice display conduction defects below the atrioventricular node (AVN) as determined by invasive electrophysiological testing. These defects are associated with decreased expression of connexin40. Our results suggest that Hop functions in the adult CCS and demonstrate conservation of molecular hierarchies between embryonic myocardium and the specialized conduction tissue of the mature heart.
Related Article:
This article has been cited by other articles:
![]() |
C. J. Hatcher and C. T. Basson Specification of the Cardiac Conduction System by Transcription Factors Circ. Res., September 25, 2009; 105(7): 620 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. V. Munshi, J. McAnally, S. Bezprozvannaya, J. M. Berry, J. A. Richardson, J. A. Hill, and E. N. Olson Cx30.2 enhancer analysis identifies Gata4 as a novel regulator of atrioventricular delay Development, August 1, 2009; 136(15): 2665 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. McNally and E. C. Svensson Setting the Pace: Tbx3 and Tbx18 in Cardiac Conduction System Development Circ. Res., February 13, 2009; 104(3): 285 - 287. [Full Text] [PDF] |
||||
![]() |
Y. Zhu, A. O. Gramolini, M. A. Walsh, Y.-Q. Zhou, C. Slorach, M. K. Friedberg, J. K. Takeuchi, H. Sun, R. M. Henkelman, P. H. Backx, et al. Tbx5-dependent pathway regulating diastolic function in congenital heart disease PNAS, April 8, 2008; 105(14): 5519 - 5524. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Asanoma, H. Kato, S. Yamaguchi, C. H. Shin, Z.-P. Liu, K. Kato, T. Inoue, Y. Miyanari, K. Yoshikawa, K. Sonoda, et al. HOP/NECC1, A Novel Regulator of Mouse Trophoblast Differentiation J. Biol. Chem., August 17, 2007; 282(33): 24065 - 24074. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M.H. Hoogaars, A. Engel, J. F. Brons, A. O. Verkerk, F. J. de Lange, L.Y. E. Wong, M. L. Bakker, D. E. Clout, V. Wakker, P. Barnett, et al. Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria Genes & Dev., May 1, 2007; 21(9): 1098 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Kee, I. S. Sohn, K. I. Nam, J. E. Park, Y. R. Qian, Z. Yin, Y. Ahn, M. H. Jeong, Y.-J. Bang, N. Kim, et al. Inhibition of Histone Deacetylation Blocks Cardiac Hypertrophy Induced by Angiotensin II Infusion and Aortic Banding Circulation, January 3, 2006; 113(1): 51 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Epstein and M. S. Parmacek Recent Advances in Cardiac Development With Therapeutic Implications for Adult Cardiovascular Disease Circulation, July 26, 2005; 112(4): 592 - 597. [Full Text] [PDF] |
||||
![]() |
G. I. Fishman Understanding Conduction System Development: A Hop, Skip and Jump Away? Circ. Res., April 29, 2005; 96(8): 809 - 811. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |